Dinesh V Ph D Patel insider trades

Open-market stock purchases and sales by Dinesh V Ph D Patel, President and CEO at Protagonist Therapeutics, Inc, from SEC Form 4 filings since Oct 11, 2016.

Recent trades

DateStockTradeValue
May 12, 2026PTGX Protagonist Therapeutics, IncSold$7.5M
May 12, 2026PTGX Protagonist Therapeutics, IncBought (not open market)—
May 12, 2026PTGX Protagonist Therapeutics, IncSold$7.5M
May 12, 2026PTGX Protagonist Therapeutics, IncBought (not open market)—
Apr 23, 2026PTGX Protagonist Therapeutics, IncSold (not open market)—
Mar 25, 2026PTGX Protagonist Therapeutics, IncSold$5.5M
Mar 25, 2026PTGX Protagonist Therapeutics, IncBought (not open market)—
Mar 24, 2026PTGX Protagonist Therapeutics, IncSold$6K
Mar 24, 2026PTGX Protagonist Therapeutics, IncBought (not open market)—
Mar 23, 2026PTGX Protagonist Therapeutics, IncSold (not open market)—
Jan 27, 2026PTGX Protagonist Therapeutics, IncSold$338K
Jan 27, 2026PTGX Protagonist Therapeutics, IncBought (not open market)—
Jan 26, 2026PTGX Protagonist Therapeutics, IncSold$898K
Jan 26, 2026PTGX Protagonist Therapeutics, IncSold$1.2M
Jan 26, 2026PTGX Protagonist Therapeutics, IncBought (not open market)—
Jan 26, 2026PTGX Protagonist Therapeutics, IncBought (not open market)—
Jan 23, 2026PTGX Protagonist Therapeutics, IncSold (not open market)—
Jan 23, 2026PTGX Protagonist Therapeutics, IncSold$1.6M
Jan 23, 2026PTGX Protagonist Therapeutics, IncBought (not open market)—
Jan 20, 2026PTGX Protagonist Therapeutics, IncSold$2.8M
Jan 2, 2026PTGX Protagonist Therapeutics, IncBought (not open market)—
Jan 2, 2026PTGX Protagonist Therapeutics, IncBought (not open market)—
Nov 21, 2025PTGX Protagonist Therapeutics, IncSold (not open market)—

Companies traded

  • PTGX Protagonist Therapeutics, Inc: 2 buys, 25 sales, last May 12, 2026

Get free alerts when Dinesh V Ph D Patel files a new trade →